Pharmafile Logo
Pharmafocus logo
Advanced Search

PureTech Founded Entity Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMID

April 17, 2023
Business Services

CAMBRIDGE, MA, April 17, 2023 – Vedanta Biosciences, a clinical-stage company that is developing a potential new category of oral therapies based …

News
Press release
national-cancer-institute-kluafqlacfw-unsplash

Companies showcase innovative biotech at American Association for Cancer Research

April 17, 2023
Medical Communications

Leading companies in the biotechnology sector will showcase their latest innovations at the American Association for Cancer Research (AACR) meeting …

News

Complement Therapeutics gains €72m in Series A financing for novel therapeutics research

April 17, 2023
Medical Communications

Preclinical stage biotechnology company Complement Therapeutics (CTx) has announced the completion of its Series A financing round, led by Gimv, …

News
towfiqu-barbhuiya-ssz6x-gao0c-unsplash

GSK announces positive data from phase 3 trial for new UTI antibiotic

April 17, 2023
Research and Development

GSK has shared positive data from its phase 3 trial for gepotidacin as a new oral antibiotic for the treatment …

News
volodymyr-hryshchenko-m1hq4ibp9rc-unsplash

Merck acquires Prometheus Biosciences, strengthens immunology pipeline

April 17, 2023
Sales and Marketing

Merck (known as MSD outside of the US and Canada) has announced that it, through a subsidiary, has agreed to …

News

MorphoSys and Incyte Announce Five-Year Results of L-MIND Study Showed Prolonged, Durable Responses in Relapsed or Refractory DLBCL Patients Treated with Monjuvi® (tafasitamab-cxix)

April 17, 2023
Business Services

BOSTON and WILMINGTON, Del. – April 16, 2023 – MorphoSys U.S. Inc., a fully owned subsidiary of MorphoSys AG (FSE: …

News
Press release

MinervaX Commences First Phase 1 Clinical Study of Novel GBS Vaccine in Older Adults

April 17, 2023
Business Services

Copenhagen, Denmark, 17 April 2023 – MinervaX ApS, a privately held Danish biotechnology company developing a novel vaccine against Group …

News
Press release

MindMed Collaborators Announce Positive Topline Data from Phase 2 Trial of Lysergide (LSD) in Major Depressive Disorder (MDD)

April 14, 2023
Business Services

NEW YORK, April 14, 2023 — Mind Medicine (MindMed) Inc (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical …

News
Press release
mark-paton-bmzkw_nn0pq-unsplash

Neuromod closes €30m financing for new tinnitus treatment device

April 14, 2023
Sales and Marketing

Irish medical device company Neuromod has announced that it has successfully closed a €30m financing intended to further commercialise Lenire, …

News
towfiqu-barbhuiya-msqb97guxy0-unsplash

Diabeloop announces collaboration with Novo Nordisk for connected diabetes treatment

April 14, 2023
Research and Development

Automated insulin delivery company Diabeloop has announced its collaboration with global healthcare company Novo Nordisk, with an agreement which covers …

News
steven-hwg-zbsdrthiim4-unsplash

Merck’s relapsing multiple sclerosis trial put on FDA partial clinical hold over liver injuries

April 14, 2023
Research and Development

Merck has announced that its clinical phase 3 study EVOLUTION has been put on partial clinical hold by the FDA …

News
pawel-czerwinski-2y8ol_obs1i-unsplash_2

FDA declines Eli Lilly’s bowel disease drug over manufacturing issues

April 14, 2023
Manufacturing and Production

Pharma giant Eli Lilly’s Biologic Licence Application (BLA) for its bowel disease drug has been declined by the FDA over …

News

UCB’s Rozanolixizumab and Zilucoplan Phase 3 Generalized Myasthenia Gravis studies published in prestigious The Lancet Neurology Journal

April 13, 2023
Business Services

Brussels (Belgium) 13 April 2023 – 07:00 AM (CET) – UCB, a global biopharmaceutical company, today announced that The Lancet Neurology …

News
Press release

Adaptyv Bio creates a new paradigm for protein engineering using generative AI, open-source software and synthetic biology

April 13, 2023
Business Services

Lausanne, Switzerland – 13th April 2023; AI tools like ChatGPT are revolutionizing how the world generates text, images and code. …

News
Press release

BioInnovation Institute & Science Prize for Innovation winners announced

April 13, 2023
Business Services

COPENHAGEN, Denmark, April 13, 2023 – BioInnovation Institute (BII), an international non-profit foundation incubating and accelerating world-class life science research, …

News
Press release

Adcendo ApS to Present Data on the Expression of the Novel ADC target uPARAP in Soft Tissue and Bone Sarcoma at the 2023 American Association for Cancer Research (AACR) Annual Meeting

April 13, 2023
Sales and Marketing

Copenhagen, Denmark, 13 April, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) …

News
Press release

ANGLE plc (“the Company”) Pharma Services Contract with Crescendo Biologics

April 13, 2023
Business Services

ANGLE plc (AIM: AGL; OTCQX: ANPCY), a world-leading liquid biopsy company, is delighted to announce that it has signed a …

News
Press release

Transgene’s Board of Directors Proposes the Appointment of Carol Stuckley, MBA, as New Independent Director

April 13, 2023
Business Services

Strasbourg, France, April 12, 2023, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops …

Appointment

Alentis Therapeutics closes $105m Series C funding for new treatment options

April 13, 2023
Sales and Marketing

Alentis Therapeutics has announced $105m in Series C funding which was led by Jeito Capital together with Novo Holdings A/S …

News
robina-weermeijer-3kgf9r_0ohs-unsplash_2

Biogen announces licensing of Denali’s ATV to target Amyloid Beta

April 13, 2023
Research and Development

Biogen and Denali Therapeutics have announced that Biogen has exercised its option to license Denali’s Antibody Transport Vehicle: Amyloid beta …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026